KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Molina Healthcare (MOH) EBITDA (2016 - 2025)

Molina Healthcare (MOH) has disclosed EBITDA for 16 consecutive years, with $459.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 20.79% to $459.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, down 2.06% year-over-year, with the annual reading at $788.0 million for FY2025, 54.27% down from the prior year.
  • EBITDA hit $459.0 million in Q4 2025 for Molina Healthcare, up from $108.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $467.0 million in Q3 2024 to a low of $9.0 million in Q1 2021.
  • Historically, EBITDA has averaged $178.8 million across 5 years, with a median of $108.0 million in 2024.
  • Biggest YoY gain for EBITDA was 2000.0% in 2021; the steepest drop was 93.08% in 2021.
  • Year by year, EBITDA stood at $13.0 million in 2021, then skyrocketed by 2476.92% to $335.0 million in 2022, then fell by 5.67% to $316.0 million in 2023, then grew by 20.25% to $380.0 million in 2024, then increased by 20.79% to $459.0 million in 2025.
  • Business Quant data shows EBITDA for MOH at $459.0 million in Q4 2025, $108.0 million in Q3 2025, and $373.0 million in Q2 2025.